je.st
news
Novogen Identifies Highly Active Drug Candidates Against Prostate Cancer
2014-06-04 12:52:32| drugdiscoveryonline News Articles
Novogen Limited (NASDAQ: NVGN, ASX:NRT), an oncology drug development company, today announced that it has achieved a key milestone with its super-benzopyran (SBP) drug program, having identified a number of SBP compounds with potent anti-cancer activity against human prostate cancer cells in vitro
Tags: active
highly
drug
cancer
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||